[Source: KVOA.com] – A small business grant will help an Arizona-based company develop a drug for Valley Fever.
Valley Fever Solutions Inc (VFS) has been awarded $3 million from the National Institutes for Health (NIH) to continue the commercialization of nikkomycin Z (NikZ), a potentially curative therapy for Valley Fever.
Starting this week, the funds will be administered over the next three-years by the National Center for Minority Health and Health Disparities, one of the institutes and centers of the NIH.
For more information: Small business grant will help develop Valley Fever drug here